# Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc. is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** Theseus Pharmaceuticals, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001745020

## About

Theseus Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001745020, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-09, it reported net income of USD -50,608,000; total assets of USD 222,447,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Net income:** -$50.6M (USD -50,608,000)
- **Total assets:** $222.4M (USD 222,447,000)
- **Cash and equivalents:** $94.6M (USD 94,605,000)
- **Operating cash flow:** -$32.9M (USD -32,945,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$27.3M (USD -27,308,000)
- **Total assets:** $250.9M (USD 250,929,000)
- **Cash and equivalents:** $244.7M (USD 244,662,000)
- **Operating cash flow:** -$27.2M (USD -27,193,000)

## Recent SEC filings

- Form 8-K — filed 2024-02-14 — period 2024-02-14 — FORM 8-K
- Form 8-K — filed 2023-12-22 — period 2023-12-21 — FORM 8-K
- Form 8-K — filed 2023-12-04 — period 2023-11-29 — FORM 8-K
- Form 8-K — filed 2023-11-27 — period 2023-11-22 — FORM 8-K
- Form SC 13D — filed 2023-11-24
- Form 10-Q — filed 2023-11-17 — period 2023-09-30 — 10-Q
- Form 8-K — filed 2023-11-13 — period 2023-11-06 — 8-K
- Form 8-K — filed 2023-10-31 — period 2023-10-27 — 8-K
- Form 10-Q — filed 2023-08-10 — period 2023-06-30 — 10-Q
- Form 8-K — filed 2023-08-10 — period 2023-08-10 — 8-K
- Form 8-K — filed 2023-07-13 — period 2023-07-13 — FORM 8-K
- Form 8-K — filed 2023-06-09 — period 2023-06-09 — 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/theseus-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology